
Epidermal cell sheet finds extensive applications in regenerative medicine for treating patients with skin disorders, and does possess the potential to threat limbal stem cell deficiency (LSCD), as per demonstration in varying animal models. Rising demand for epidermal care, driven by sensitive skin ailments, is a key factor spurring revenue of epidermal cell sheet market. Rising need to safeguard skin from infectious agents is also providing fillip to sales of epidermal cell sheet by a notable margin. Consumers, with a rapid transition toward healthy lifestyles, are showing marked preferences for a wide range of epidermal cell sheets facilitating protection, exfoliation, and nourishment, which remain highly-valued among the customers.